NFE2L2 and pancreatic ductal adenocarcinoma: According to Chio et al., combined targeting inhibition of Akt signaling and synthesis of glutathione could mimic Nrf2 ablation and effectively inhibit the survival of pancreatic ductal adenocarcinoma cells (PDACs) in vitro and in vivo [58].